0001140361-18-038414.txt : 20180913 0001140361-18-038414.hdr.sgml : 20180913 20180913174330 ACCESSION NUMBER: 0001140361-18-038414 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180910 FILED AS OF DATE: 20180913 DATE AS OF CHANGE: 20180913 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRAENDER LORI J CENTRAL INDEX KEY: 0001752955 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38599 FILM NUMBER: 181069667 MAIL ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aquestive Therapeutics, Inc. CENTRAL INDEX KEY: 0001398733 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208623253 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-941-1900 MAIL ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: MonoSol Rx, Inc. DATE OF NAME CHANGE: 20070507 4 1 form4.xml FORM 4 X0306 4 2018-09-10 0001398733 Aquestive Therapeutics, Inc. AQST 0001752955 BRAENDER LORI J C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE WARREN NJ 07059 true SVP, General Counsel Stock Option (Right to Purchase) 18.67 2018-09-10 4 A 0 85000 0 A 2028-09-10 Common Stock 85000 85000 D The shares underlying the options vest in three annual installments of 25%, 25% and 50% on September 10, 2019, September 10, 2020 and September 10, 2021, respectively, subject in each case to Ms. Braender's continuous service with the Issuer from the grant date through the applicable vesting date. /s/ Robert Arnold, as Attorney-In-Fact 2018-09-13